drugset / Trial / NCT01038921
Melatonin and the Metabolic Syndrome
RandomizedCrossoverDouble-blindTreatment
Summary
This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
Timeline
- Start
- 2009-07
- Primary completion
- 2012-06
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 8 mg | Oral |